ISIN | CH0210193584 |
---|---|
Valor Number | 21019358 |
Bloomberg Global ID | UBS65QD SW |
Fund Name | UBS (CH) Suisse - 65 (CHF) Q-dist |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Asset Allocation |
EFC Category | Multi-Asset Global Advanced Markets Aggressive |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Well diversified portfolio with a focus on selected Swiss bonds, equities and real estate, complemented by a component of global bonds and equities|Equity weighting 65% |
Peculiarities |
Current Price * | 136.24 CHF | 03.07.2025 |
---|---|---|
Previous Price * | 135.99 CHF | 02.07.2025 |
52 Week High * | 137.78 CHF | 13.02.2025 |
52 Week Low * | 123.24 CHF | 09.04.2025 |
NAV * | 136.24 CHF | 03.07.2025 |
Issue Price * | 136.49 CHF | 03.07.2025 |
Redemption Price * | 136.49 CHF | 03.07.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 447,574,426 | |
Unit/Share Assets *** | 24,053,340 | |
Trading Information SIX |
YTD Performance | +4.48% |
31.12.2024 - 03.07.2025
31.12.2024 03.07.2025 |
---|---|---|
1 month | +0.12% |
03.06.2025 - 03.07.2025
03.06.2025 03.07.2025 |
3 months | +3.65% |
03.04.2025 - 03.07.2025
03.04.2025 03.07.2025 |
6 months | +4.08% |
03.01.2025 - 03.07.2025
03.01.2025 03.07.2025 |
1 year | +5.06% |
03.07.2024 - 03.07.2025
03.07.2024 03.07.2025 |
2 years | +13.26% |
03.07.2023 - 03.07.2025
03.07.2023 03.07.2025 |
3 years | +16.87% |
04.07.2022 - 03.07.2025
04.07.2022 03.07.2025 |
5 years | +22.59% |
03.07.2020 - 03.07.2025
03.07.2020 03.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
UBS InvF Equities USA Index I-X-acc | 11.05% | |
---|---|---|
UBS CH IF3 RealEstSwitzFdsIdxNSL I-Xacc | 9.87% | |
UBS (CH) IF S&M Cap Equities Switz I-X | 9.08% | |
UBS (CH) IF Bds CHF Inl Corp Pasv II U-X | 7.23% | |
Nestle SA | 5.28% | |
UBS (CH) IF Bds CHF Frgn CI NSL U-X-acc | 4.83% | |
UBS (CH) IF Bds CHF Prime Ausland U-X | 4.47% | |
Roche Holding AG | 4.28% | |
Novartis AG Registered Shares | 4.11% | |
UBS (Lux) BS USDInvmGrdCor$CHF H UX acc | 4.03% | |
Last data update | 31.05.2025 |
TER | 1.05% |
---|---|
TER date | 31.08.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.95% |
Ongoing Charges *** | 1.06% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |